Join our Milliman and Wakely presenters as they discuss the latest changes to the Medicare regulatory landscape and the impact of the pandemic on 2022 bid pricing considerations. We will discuss developing changes from the Biden administration, new regulatory changes from CMS that address the COVID-19 pandemic, and recently announced drug pricing rules.
Presenter(s)
Thomas John Grivakis FSA,MAAA
Consulting Actuary
Wakely Consulting Group
Hayley Marin Rogers FSA,MAAA
Milliman Inc
Emily Jayne Vandermause FSA,MAAA
Consulting Actuary
Milliman Inc
Moderator(s)
Deana K. Bell, FSA, MAAA
Principal & Consulting Actuary
Milliman Inc
-
1.80 SOA CPD
1.50 CIA
-
Member $125.00Non Member $150.00*Other discounts may apply
-
Presented By:
Health Section
